翻訳と辞書 |
Galapagos Genomics : ウィキペディア英語版 | Galapagos Genomics Galapagos Genomics NV was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. The Company later changed its name to Galápagos NV and completed its initial public offering on Euronext Amsterdam and Euronext Brussels in May 2005. The company uses a technological platform for its research, which is based on adenoviruses to introduce human gene sequences into a wide variety of human cell lines to knock-in or knock-down specific proteins. Onno van de Stolpe is the CEO of the company. ==See also==
*FlandersBio
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Galapagos Genomics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|